Earnings Outlook: What to expect from Johnson & Johnson earnings

Coming off the heels of a strong fiscal year, Johnson & Johnson is expected to report yet another strong quarter during its earnings release, scheduled for Tuesday before the market open.

The multinational JNJ, +0.04% saw steady revenue and earnings growth last year, which came in sharp contrast with the previous year’s declines. Wall Street analysts are expecting fourth-quarter results to reflect that growth, but guidance for 2017 is a whole different story.

This year “certainly won’t be as easy,” said J.P. Morgan analyst Michael Weinstein, projecting conservative guidance for the year.

New competition may slow its pharmaceutical business growth, and a strong dollar could pose challenges for the company’s biggest business units, Weinstein said.

>>> Original Source <<<